Skip to main content

Erratum to: Impact of intravenous fluid composition on outcomes in patients with systemic inflammatory response syndrome

The Original Article was published on 01 December 2015

After the publication of this article it has been brought to our attention that the data in Table 3 (Table 1 in this Erratum) and in the Additional file 3: Table S3 (Additional File 1 in this Erratum) contained mistakes as detailed below. These mistakes have been corrected in this Erratum.

Table 3 Administrative and clinical outcomes by fluid cohort

The following values have been corrected in Table 3 (Table 1 in this Erratum):

  • the entire column (far right) "Adjusted Odds Ratio (95 % CI)"

  • under Electrolyte Abnormalities, the value for "High Mg" within the column "Saline n (%)" and the values for "Unadjusted Odds Raio (95 % CI)" and "Adjusted Odds Ratio (95 % CI)"

  • under Electrolyte Abnormalities, ALL values for the row labelled "Low Ca with replacement"

The single value for SOFA CV Level 2 "Saline cohort n (%)" in Table S3 (Additional File 1 in this Erratum) has been corrected.

In addition, we noticed that the legend for Fig. 2 (Fig. 1 in this Erratum) was incorrectly given as “Administrative and clinical outcomes unadjusted and adjusted for Acute Physiology Score”. The correct legend for Fig. 2 is “Administrative and clinical outcomes unadjusted and adjusted for APS, Elixhauser comorbidities of congestive heart failure, hypertension and lymphoma, admission source, census region, and payer.” The labels above the right-hand side plots within the figure also needed corrections and have been updated in this erratum.

Fig. 2
figure 1

legend, edit to: Administrative and clinical outcomes unadjusted and adjusted for APS, Elixhauser comorbidities of congestive heart failure, hypertension and lymphoma, admission source, census region, and payer

Reference

  1. Shaw AD, Schermer CR, Lobo DN, Munson SH, Khangulov V, Hayashida DK, et al. Impact of intravenous fluid composition on outcomes in patients with systemic inflammatory response syndrome. Critical Care. 2015;19:334.

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Andrew D. Shaw.

Additional information

The online version of the original article can be found under doi:10.1186/s13054-015-1045-z.

Additional file

Additional file 3: Table S3.

SOFA Outcomes by Treatment Group. (DOCX 12 kb)

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shaw, A.D., Schermer, C.R., Lobo, D.N. et al. Erratum to: Impact of intravenous fluid composition on outcomes in patients with systemic inflammatory response syndrome. Crit Care 20, 17 (2015). https://doi.org/10.1186/s13054-016-1187-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13054-016-1187-7